WIN Consortium
Membership Organizations · France · 1-10 Employees
View Company Info for Free
Overview
Headquarters
24 Rue Albert Thuret, Chevilly-Larue, Il...Website
www.winconsortium.orgRevenue
<$5 MillionIndustry
About WIN Consortium
Is WIN Consortium your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if WIN Consortium is spiking on competitors!
Funding: Get notified immidiatlly once WIN Consortium has new funding data
Check if WIN Consortium has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when WIN Consortium launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on WIN Consortium recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at WIN Consortium
Website visits: Recent activity has been detected on your website
Click to see if WIN Consortium had a recent Job posting/layoffs
WIN Consortium, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined WIN Consortium as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
WIN Consortium is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
WIN Consortium is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about WIN Consortium.
WIN Consortium Tech Stack
A closer look at the technologies used by WIN Consortium
WIN Consortium News & Media
WIN 2019 Symposium: WINnovation and Global Deployment of Precision Oncology
VILLEJUIF, France--(BUSINESS WIRE)--ASCO® endorsed for the past 11 years, the WIN symposium will deliver an exciting line-up of speakers in Paris (France) on June 23-24, 2019. Join us.WINTHER trial results
(WIN Consortium) Published in Nature Medicine, results of WINTHER, the first study pioneered by the WIN Consortium -- Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial -- shows that RNA profiling together with DNA testing matches more patients with advanced cancer to personalized therapies than DNA profiling for tumor mutations alone.Comprehensive Tumor Profiling Promises New Therapeutic Options for Patients with Advanced Cancer
VILLEJUIF, France--(BUSINESS WIRE)--Published in Nature Medicine, results of WIN Consortium - - Genomic and transcriptomic profiling expands precision cancer medicine: WINTHER trial.
Top Membership Organizations Companies
Frequently Asked Questions Regarding WIN Consortium
The WIN Consortium is a global non-profit organization focused on advancing precision oncology through international collaboration among cancer centers, life sciences, and technology companies. Established in 2010, it aims to improve cancer patient outcomes by facilitating clinical trials and research projects that leverage genomic-based therapies.... Read More